286 related articles for article (PubMed ID: 12681023)
1. Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.
Jones TA; Sautter M; Van Gaal LF; Jones NP
Diabetes Obes Metab; 2003 May; 5(3):163-70. PubMed ID: 12681023
[TBL] [Abstract][Full Text] [Related]
2. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone.
Hamann A; Garcia-Puig J; Paul G; Donaldson J; Stewart M
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):6-13. PubMed ID: 18095238
[TBL] [Abstract][Full Text] [Related]
4. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
Fonseca V; Rosenstock J; Patwardhan R; Salzman A
JAMA; 2000 Apr; 283(13):1695-702. PubMed ID: 10755495
[TBL] [Abstract][Full Text] [Related]
5. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
Rosenstock J; Rood J; Cobitz A; Huang C; Garber A
Diabetes Obes Metab; 2006 Nov; 8(6):643-9. PubMed ID: 17026488
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.
Bailey CJ; Bagdonas A; Rubes J; McMorn SO; Donaldson J; Biswas N; Stewart MW
Clin Ther; 2005 Oct; 27(10):1548-61. PubMed ID: 16330291
[TBL] [Abstract][Full Text] [Related]
7. Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.
Goldstein BJ; Weissman PN; Wooddell MJ; Waterhouse BR; Cobitz AR
Curr Med Res Opin; 2006 Sep; 22(9):1715-23. PubMed ID: 16968575
[TBL] [Abstract][Full Text] [Related]
8. Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes.
Rosenstock J; Chou HS; Matthaei S; Seidel DK; Hamann A
Diabetes Obes Metab; 2008 Sep; 10(10):862-73. PubMed ID: 18201206
[TBL] [Abstract][Full Text] [Related]
9. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
11. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.
Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H
Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes.
Gómez-Perez FJ; Fanghänel-Salmón G; Antonio Barbosa J; Montes-Villarreal J; Berry RA; Warsi G; Gould EM
Diabetes Metab Res Rev; 2002; 18(2):127-34. PubMed ID: 11994904
[TBL] [Abstract][Full Text] [Related]
13. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
[TBL] [Abstract][Full Text] [Related]
14. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
15. A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 diabetes mellitus patients.
Borges JL; Bilezikian JP; Jones-Leone AR; Acusta AP; Ambery PD; Nino AJ; Grosse M; Fitzpatrick LA; Cobitz AR
Diabetes Obes Metab; 2011 Nov; 13(11):1036-46. PubMed ID: 21682834
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients.
Negro R; Mangieri T; Dazzi D; Pezzarossa A; Hassan H
Diabetes Res Clin Pract; 2005 Oct; 70(1):20-5. PubMed ID: 16126119
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus.
Reynolds LR; Konz EC; Frederich RC; Anderson JW
Diabetes Obes Metab; 2002 Jul; 4(4):270-5. PubMed ID: 12099976
[TBL] [Abstract][Full Text] [Related]
18. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial.
Derosa G; Gaddi AV; Piccinni MN; Salvadeo S; Ciccarelli L; Fogari E; Ghelfi M; Ferrari I; Cicero AF
Diabetes Obes Metab; 2006 Mar; 8(2):197-205. PubMed ID: 16448524
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.
Kiayias JA; Vlachou ED; Theodosopoulou E; Lakka-Papadodima E
Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
